P897: EVALUATION OF THE PROGNOSTIC IMPACT OF SECOND LINE ANTI-MYELOMA TREATMENTS ON POST- PROGRESSION OUTCOMES IN THE REAL-WORLD SETTING: THE GREEK MYELOMA STUDY GROUP EXPERIENCE.

• Eirini Katodritou,
• Efstathios Kastritis,
• Dimitra Dalampira,
• Fotini Theodorakakou,
• Sosana Delimpasi,
• Emmanouil Spanoudakis,
• Ioannis Ntanasis-Stathopoulos,
• Theodosia Papadopoulou,
• Aggeliki Sevastoudi,
• Theodora Triantafyllou,
• Aikaterini Daiou,
• Vasiliki Labropoulou,
• Anastasia Pouli,
• Maria Roussou,
• Maria Gavriatopoulou,
• Evgenia Verrou,
• Meletios A. Dimopoulos,
• Evangelos Terpos

Affiliations

Eirini Katodritou

1 Theagenion Cancer Hospital, Department of Hematology, Thessaloniki, Greece

Efstathios Kastritis

2 National and Kapodistrian University of Athens, Department of Clinical Therapeutics, Athens, Greece

Dimitra Dalampira

1 Theagenion Cancer Hospital, Department of Hematology, Thessaloniki, Greece

Fotini Theodorakakou

2 National and Kapodistrian University of Athens, Department of Clinical Therapeutics, Athens, Greece

Sosana Delimpasi

3 Evangelismos General Hospital, Department of Hematology and Bone Marrow Transplantation Unit

Emmanouil Spanoudakis

4 Democritus University of Thrace, Medical School, Department of Hematology, Alexandroupolis, Greece

Ioannis Ntanasis-Stathopoulos

2 National and Kapodistrian University of Athens, Department of Clinical Therapeutics, Athens, Greece

Theodosia Papadopoulou

1 Theagenion Cancer Hospital, Department of Hematology, Thessaloniki, Greece

Aggeliki Sevastoudi

1 Theagenion Cancer Hospital, Department of Hematology, Thessaloniki, Greece

Theodora Triantafyllou

1 Theagenion Cancer Hospital, Department of Hematology, Thessaloniki, Greece

Aikaterini Daiou

1 Theagenion Cancer Hospital, Department of Hematology, Thessaloniki, Greece

Vasiliki Labropoulou

5 University of Patras Medical School, Department of Internal Medicine, Division of Hematology, Patras, Greece

Anastasia Pouli

6 Agios Savvas Cancer Hospital, Department of Hematology, Athens, Greece

Maria Roussou

2 National and Kapodistrian University of Athens, Department of Clinical Therapeutics, Athens, Greece

Maria Gavriatopoulou

2 National and Kapodistrian University of Athens, Department of Clinical Therapeutics, Athens, Greece

Evgenia Verrou

1 Theagenion Cancer Hospital, Department of Hematology, Thessaloniki, Greece

Meletios A. Dimopoulos

2 National and Kapodistrian University of Athens, Department of Clinical Therapeutics, Athens, Greece

Evangelos Terpos

2 National and Kapodistrian University of Athens, Department of Clinical Therapeutics, Athens, Greece